3540 — CI Medical Co Income Statement
0.000.00%
Last trade - 00:00
- ¥40bn
- ¥55bn
- ¥46bn
- 43
- 41
- 39
- 32
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28,763 | 37,394 | 41,205 | 42,891 | 45,628 |
Cost of Revenue | |||||
Gross Profit | 7,753 | 11,294 | 11,605 | 11,673 | 11,995 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 26,663 | 32,924 | 36,977 | 39,084 | 42,526 |
Operating Profit | 2,100 | 4,470 | 4,228 | 3,807 | 3,102 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,149 | 4,451 | 4,285 | 3,851 | 3,184 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,506 | 2,921 | 2,821 | 2,525 | 2,100 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,506 | 2,921 | 2,821 | 2,522 | 2,084 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,506 | 2,921 | 2,820 | 2,521 | 2,082 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 150 | 307 | 301 | 266 | 208 |
Dividends per Share | |||||
Special Dividends per Share |